Improving kidney function during donor anesthesia
Official title: Renal Graft Functional Enhancement During Donor Anesthesia: A Comparative Study of 3 Modalities
Run by Cairo University · NCT03778944 · Data updated 2026-11-12
This study tests whether giving Mannitol, Dopamine, or extra fluids during anesthesia can help improve kidney function for patients receiving a kidney transplant from a living donor.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | December 20, 2018 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT03778944 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals with end-stage renal disease who are scheduled for living-donor kidney transplantation.
✕Probably not a fit
Patients with severe cardiac or hepatic dysfunction or coagulopathy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of three different interventions—Mannitol infusion, Dopamine infusion, and adequate hydration—on enhancing the function and perfusion of transplanted kidneys during donor anesthesia. It aims to determine which approach best supports renal graft function in patients undergoing living-donor kidney transplantation. The study focuses on patients with end-stage renal disease and compares the outcomes of the different anesthetic regimens.
Why it matters
Potential benefit: If successful, this study could lead to improved kidney function and outcomes for patients receiving transplants.
How similar studies have gone: While there have been studies focusing on renal graft function, the specific combination of interventions in this study is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * end-stage renal disease, for living-donor kidney transplantation Exclusion Criteria: * severe cardiac or hepatic dysfunction * coagulopathy
Where it's running
-
Kasr Al-Ainy Hospital, Cairo University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Nazmy E Seif, MD
- Email: drnazmyseif@yahoo.com
- Phone: 01227400808
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transplanting abdominal wall tissue to repair defects
This study is testing if transplanting abdominal wall tissue can safely fix defects in the abdominal area for people who need it.
-
Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Personalization of Immunosuppression
This study tests whether non-invasive biomarkers can guide care in kids with kidney transplants to reduce biopsies and tailor immunosuppressive drug exposure.
-
Virtual home-based exercise program for kidney transplant candidates
This study is testing a 12-week online exercise and education program for people waiting for a kidney transplant to see if it helps them get stronger before surgery.
-
Assessing diabetes risk in cirrhosis patients before and after liver transplant
This study is trying to find out what factors might lead to diabetes in adults with liver cirrhosis before and after they get a liver transplant.
-
XVIVO Heart Box non-ischemic preservation for transporting donor hearts.
This program tests whether the XVIVO non-ischemic heart preservation system can safely preserve extended-criteria donor hearts for adults waiting for a heart transplant.
-
Examining the effects of furosemide on toxin levels in chronic kidney disease patients
This study is testing whether the diuretic furosemide affects the levels of certain toxins in the blood and urine of people with chronic kidney disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.